FP7H2020HORIZON
Universitaetsklinikum Freiburg
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 124
- As coordinator
- 37
- EU contribution (CORDIS)
- EUR 64,486,497
- Active
- 2008 to 2025
Projects
124 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| MAGIXMucociliary adaptations and gut microbiome establishment in Xenopus | HORIZON | 2025 | Coordinator | EUR 1,995,921 |
| SP-EUSocial Prescribing to promote and improve access to health and care services for people in vulnerable situations in Europe | HORIZON | 2025 | Participant | EUR 367,163 |
| DRESSCODEEngineering next-generation fusion proteins to dress the cell membrane with functionally enhanced receptors | HORIZON | 2024 | Coordinator | EUR 1,497,778 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 200,462 |
| ECLecticElectroChemiLuminescence doctoral network for early sepsis diagnosis | HORIZON | 2024 | Participant | EUR 260,539 |
| STIC-GBMSpatio-temporal dynamics of immune circuitry in glioblastoma: from single cells to comprehensive models of tumor niches | HORIZON | 2024 | Coordinator | EUR 173,847 |
| AlloCureDeciphering cellular signalling to cure graft-versus-host disease (GVHD) and leukemia relapse | HORIZON | 2023 | Coordinator | EUR 2,498,943 |
| exTraInnovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation | HORIZON | 2023 | Participant | EUR 260,539 |
| NEXUSautomated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS | HORIZON | 2022 | Participant | EUR 425,000 |
| geneTIGAGene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology | HORIZON | 2022 | Participant | EUR 1,000,312 |
| SOLSwitchable rhodOpsins in Life Sciences | H2020 | 2022 | Participant | EUR 212,500 |
| TeleRehaB DSSTeleRehabilitation of Balance clinical and economic Decision Support System | HORIZON | 2022 | Participant | EUR 403,750 |
| X-PANDExploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application | HORIZON | 2022 | Participant | EUR 608,563 |
| milieuPCaDefining the immunosuppressive milieu of prostate cancer with single cell Omics technologies | H2020 | 2021 | Coordinator | EUR 174,806 |
| SISAQOL-IMIEstablishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials | H2020 | 2021 | Participant | Not stated |
| IMMUNOSTIMNovel small molecule activators of the NLRP3 inflammasome as immunostimulants | H2020 | 2021 | Coordinator | EUR 150,000 |
| ANIMATEAdaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | H2020 | 2020 | Coordinator | EUR 1,499,946 |
| PersonalizeAFPersonalized Therapies for Atrial Fibrillation. A Translational Approach | H2020 | 2020 | Participant | EUR 252,788 |
| Bat FluDeciphering the unconventional receptor binding and modulation activity of bat influenza A viruses | H2020 | 2020 | Coordinator | EUR 2,499,638 |
| TrainCKDisMultidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery | H2020 | 2020 | Participant | EUR 252,788 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.